Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Regulatory Actions
Research conducted at Stanford University has provided new information about regulatory actions
November 9th, 2008
In this recent report, researchers in the United States conducted a study "To assess the economic cost of implementing the U.S. Food and Drug Administration's Code of Federal Regulations Title 21, Part 127 h for infectious screening of egg donors in our practice during the first year." "Physicians and employees of our practice were surveyed to ascertain the scope of duties and the number of hours spent to implement the regulations. The economic cost to the practice and the cost of additional laboratories were calculated. Private practice. Patient(S): Egg donors and recipient couples who underwent treatment in our center from May 25, 2005 (the day regulations became...
Source: Medical Letter on the CDC & FDA (2008-11-09)
|
